The effect of FEZF1-AS1 on tumor growth was assessed in vivo by administering a subcutaneous injection of HCT116 with stable knockdown of FEZF1-AS1 and mock cells into the subcutaneous bilateral hind leg of mice. Here, FEZF1 is linked to neoplasm.